Cargando…

Metabolomic Biomarkers for the Detection of Obesity-Driven Endometrial Cancer

SIMPLE SUMMARY: Endometrial cancer is the commonest cancer of the female genital tract and obesity is its main modifiable risk factor. Over 80% of endometrial cancers develop in the context of obesity-induced metabolic changes. This study focuses on the potential of plasma-based metabolites to enabl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Njoku, Kelechi, Campbell, Amy E., Geary, Bethany, MacKintosh, Michelle L., Derbyshire, Abigail E., Kitson, Sarah J., Sivalingam, Vanitha N., Pierce, Andrew, Whetton, Anthony D., Crosbie, Emma J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7916512/ https://www.ncbi.nlm.nih.gov/pubmed/33578729 http://dx.doi.org/10.3390/cancers13040718

Ejemplares similares

Comprehensive Library Generation for Identification and Quantification of Endometrial Cancer Protein Biomarkers in Cervico-Vaginal Fluid
por: Njoku, Kelechi, et al.
Publicado: (2021)

Metabolomic Biomarkers for Detection, Prognosis and Identifying Recurrence in Endometrial Cancer
por: Njoku, Kelechi, et al.
Publicado: (2020)

Proteomic Biomarkers for the Detection of Endometrial Cancer
por: Njoku, Kelechi, et al.
Publicado: (2019)

Prevention Strategies in Endometrial Carcinoma
por: MacKintosh, Michelle L., et al.
Publicado: (2018)

Optimization of Window Study Endpoints in Endometrial Cancer
por: Kitson, Sarah J., et al.
Publicado: (2019)

Quantitative SWATH-based proteomic profiling of urine for the identification of endometrial cancer biomarkers in symptomatic women
por: Njoku, Kelechi, et al.
Publicado: (2023)

High prevalence of metabolic syndrome in women newly diagnosed with endometrial cancer
por: Kitson, Sarah J., et al.
Publicado: (2018)

Women’s Risk Perceptions and Willingness to Engage in Risk-Reducing Interventions for the Prevention of Obesity-Related Endometrial Cancer
por: Derbyshire, Abigail E, et al.
Publicado: (2022)

Current and Emerging Prognostic Biomarkers in Endometrial Cancer
por: Njoku, Kelechi, et al.
Publicado: (2022)

Detecting Endometrial Cancer by Blood Spectroscopy: A Diagnostic Cross-Sectional Study
por: Paraskevaidi, Maria, et al.
Publicado: (2020)

Urinary Biomarkers and Their Potential for the Non-Invasive Detection of Endometrial Cancer
por: Njoku, Kelechi, et al.
Publicado: (2020)

Impact of Type 2 Diabetes Mellitus on Endometrial Cancer Survival: A Prospective Database Analysis
por: Njoku, Kelechi, et al.
Publicado: (2022)

Urine CA125 and HE4 for the Triage of Symptomatic Women with Suspected Endometrial Cancer
por: Njoku, Kelechi, et al.
Publicado: (2022)

Serum CA125 and HE4 as Biomarkers for the Detection of Endometrial Cancer and Associated High-Risk Features
por: Barr, Chloe E., et al.
Publicado: (2022)

The unrecognized burden of cardiovascular risk factors in women newly diagnosed with endometrial cancer: A prospective case control study
por: Kitson, Sarah J., et al.
Publicado: (2018)

Impact of pre-treatment prognostic nutritional index and the haemoglobin, albumin, lymphocyte and platelet (HALP) score on endometrial cancer survival: A prospective database analysis
por: Njoku, Kelechi, et al.
Publicado: (2022)

Hypoxia and hyperglycaemia determine why some endometrial tumours fail to respond to metformin
por: Sivalingam, Vanitha N., et al.
Publicado: (2019)

Pre-treatment inflammatory parameters predict survival from endometrial cancer: A prospective database analysis
por: Njoku, Kelechi, et al.
Publicado: (2022)

The impact of obesity and bariatric surgery on circulating and tissue biomarkers of endometrial cancer risk
por: MacKintosh, Michelle L., et al.
Publicado: (2018)

Monocarboxylate Transporter 1 (MCT1) is an independent prognostic biomarker in endometrial cancer
por: Latif, Ayşe, et al.
Publicado: (2017)

Ki-67 in endometrial cancer: scoring optimization and prognostic relevance for window studies
por: Kitson, Sarah, et al.
Publicado: (2017)

DEveloping Tests for Endometrial Cancer deTection (DETECT): protocol for a diagnostic accuracy study of urine and vaginal samples for the detection of endometrial cancer by cytology in women with postmenopausal bleeding
por: Jones, Eleanor R, et al.
Publicado: (2021)

Measuring the biological effect of presurgical metformin treatment in endometrial cancer
por: Sivalingam, V N, et al.
Publicado: (2016)

Does Clinical and Biochemical Thyroid Dysfunction Impact on Endometrial Cancer Survival Outcomes? A Prospective Database Study
por: Barr, Chloe E., et al.
Publicado: (2021)

Urine CA125 and HE4 for the Detection of Ovarian Cancer in Symptomatic Women
por: Barr, Chloe E., et al.
Publicado: (2023)

Urinary biomarkers for the detection of ovarian cancer: a systematic review
por: Owens, Gemma L, et al.
Publicado: (2022)

The proportion of endometrial tumours associated with Lynch syndrome (PETALS): A prospective cross-sectional study
por: Ryan, Neil A. J., et al.
Publicado: (2020)

Oncogenic MYC amplifies mitotic perturbations
por: Littler, Samantha, et al.
Publicado: (2019)

Expression of NAD(P)H quinone dehydrogenase 1 (NQO1) is increased in the endometrium of women with endometrial cancer and women with polycystic ovary syndrome
por: Atiomo, William, et al.
Publicado: (2017)

The impact of obesity and bariatric surgery on the immune microenvironment of the endometrium
por: Naqvi, Anie, et al.
Publicado: (2021)

Targeting Endometrial Cancer Stem Cell Activity with Metformin Is Inhibited by Patient-Derived Adipocyte-Secreted Factors
por: Kitson, Sarah J., et al.
Publicado: (2019)

Weight Loss During Intrauterine Progestin Treatment for Obesity-associated Atypical Hyperplasia and Early-Stage Cancer of The Endometrium
por: Barr, Chloe E., et al.
Publicado: (2021)

Recent advances in understanding the roles of whole genome duplications in evolution
por: MacKintosh, Carol, et al.
Publicado: (2018)

¡Hamlet :venganza!
por: Stewart, John Innes MacKintosh, 1906-
Publicado: (1974)

HE4 as a Biomarker for Endometrial Cancer
por: Behrouzi, Roya, et al.
Publicado: (2021)

Baseline Serum HE4 But Not Tissue HE4 Expression Predicts Response to the Levonorgestrel-Releasing Intrauterine System in Atypical Hyperplasia and Early Stage Endometrial Cancer
por: Behrouzi, Roya, et al.
Publicado: (2020)

Effect of IRS4 Levels on PI 3-Kinase Signalling
por: Hoxhaj, Gerta, et al.
Publicado: (2013)

Impact of socio‐economic deprivation on endometrial cancer survival in the North West of England: a prospective database analysis
por: Njoku, K, et al.
Publicado: (2021)

BRCA1 and BRCA2 pathogenic variant carriers and endometrial cancer risk: A cohort study
por: Kitson, Sarah J., et al.
Publicado: (2020)

Bioinformatic and experimental survey of 14-3-3-binding sites
por: Johnson, Catherine, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_9iothqbjopuft3sp9re9nv803f